Antioxidant deficiency in cystic fibrosis: When is the right time to take action?

American Journal of Clinical Nutrition

Volumn 80, Issue 2, 2004, Pages 374-384

  Back, Evelyn I ^a   Frindt, Claudia ^b   Nohr, Donatus ^a   Frank, Juergen ^a   Ziebach, Rita ^c   Stern, Martin ^c   Ranke, Michael ^c   Biesalski, Hans K ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b Institut fur Medizinische Informationsverarbeitung   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Antioxidants; Ascorbic acid; Cystic fibrosis; F2 isoprostanes; Oxidative stress; Thiobarbituric acid reactive substances; Vitamin C; Vitamin E; tocopherol; carotene

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; CARBONYL DERIVATIVE; CAROTENOID; ISOPROSTANE; LYCOPENE; PROSTAGLANDIN F2 ALPHA; PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; CHOLESTEROL; ISOPROSTANE DERIVATIVE; ISOPROSTANE F2ALPHA III;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIOXIDANT DEFICIENCY; ARTICLE; BLOOD SAMPLING; BREATHING; CHEEK MUCOSA; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYSTIC FIBROSIS; DIET RESTRICTION; DISEASE COURSE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; INFANT; METABOLIC DISORDER; MUCOSA CELL; NEWBORN; OXIDATIVE STRESS; PLASMA; PREDICTION; PREVALENCE; VITAMIN BLOOD LEVEL; AGING; ALPHA TOCOPHEROL DEFICIENCY; ASCORBIC ACID DEFICIENCY; BLOOD; BREATH ANALYSIS; CASE CONTROL STUDY; FEMALE; MALE; METABOLISM; MOUTH MUCOSA;

ADOLESCENT; ADULT; AGING; ANTIOXIDANTS; ASCORBIC ACID DEFICIENCY; BREATH TESTS; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL; CYSTIC FIBROSIS; FEMALE; HUMANS; ISOPROSTANES; MALE; MOUTH MUCOSA; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E DEFICIENCY;

EID: 4344627804     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/80.2.374     Document Type: Article

References (34)

1. Sies H, Stahl W. Vitamins E and C, β-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 1995;62(suppl):1315S-21S.
2. van der Vliet A, Eiserich JP, Marelich GP, Halliwell B, Cross CE. Oxidative stress in cystic fibrosis: does it occur and does it matter? Adv Pharmacol 1997;38:491-513.
3. Lancellotti L, D'Orazio C, Mastella G, Mazzi G, Lippi U. Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation. Eur J Pediatr 1996; 155:281-5.
4. Homnick DN, Cox JH, DeLoof MJ, Ringer TV. Carotenoid levels in normal children and in children with cystic fibrosis. J Pediatr 1993;122(5 Pt 1):703-7.
5. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients. Am J Clin Nutr 2002;75:668-75.
6. Range SP, Dunster C, Knox AJ, Kelly FJ. Treatment of pulmonary exacerbations of cystic fibrosis leads to improved antioxidant status. Eur Respir J 1999;13:560-4.
7. McGrath LT, Mallon P, Dowey L, et al. Oxidative stress during acute respiratory exacerbations in cystic fibrosis. Thorax 1999;54:518-23.
8. Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al. Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. (Percentiles for the body mass index in German children and adolescents under consideration of various random samples). Monatsschr Kinderheilkd 2001;149:807-18 (in German).
9. Robert-Koch-Institut. Bundesgesundheitssurvey 1998. (Federal Health Survey 1998). Gesundheitswesen 1999;61:115-20 (in German).
10. Gilbert AM, Stich HF, Rosin MP, Davison AJ. Variations in the uptake of β-carotene in the oral mucosa of individuals after 3 days of supplementation. Int J Cancer 1990;45:855-9.
11. Ihara H, Shino Y, Aoki Y, Hashizume N, Minegishi N. A simple and rapid method for the routine assay of total ascorbic acid in serum and plasma using ascorbate oxidase and o-phenylenediamine. J Nutr Sci Vitaminol (Tokyo) 2000;46:321-4.
12. Ihara H, Matsumoto N, Shino Y, et al. An automated assay for measuring serum ascorbic acid with use of 4-hydroxy-2,2,6,6-tetramethyl-piperidinyloxy, free radical and o-phenylenediamine. Clin Chim Acta 2000;301:193-204.
13. Erhardt JG, Mack H, Sobeck U, Biesalski HK. β-Carotene and á-tocopherol concentration and antioxidant status in buccal mucosal cells and plasma after oral supplementation. Br J Nutr 2002;87:471-5.
14. Natarajan N, Shambaugh GE III, Elseth KM, Haines GK, Radosevich JA. Adaptation of the diphenylamine (DPA) assay to a 96-well plate tissue culture format and comparison with the MTT assay. Biotechniques 1994;17:166-71.
15. Jentzsch AM, Bachmann H, Fürst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996;20:251-6.
16. Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 1997;23:361-6.
17. Biesalski HK. Vitamine. In: Biesalski HK, Fürst P, Kasper H, et al, eds. Ernährungsmedizin (Nutritional medicine). 2. Auflage. Stuttgart: Georg Thieme Verlag, 1999:111-58 (in German).
18. Biesalski HK, Böhles W, Esterbauer H, et al. Antioxidant vitamins in prevention. Clin Nutr 1997;16:151-5.
19. Deutsche Gesellschaft für Ernährung. Referenzwerte für die Nährstoffzufuhr. (Reference values for nutrient intake.) 1. Auflage. Frankfurt am Main: Umschau/Braus- Verlag, 2000 (in German).
20. Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press, 2000.
21. Winklhofer-Roob BM, Ellemunter H, Fruhwirth M, et al. Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation. Am J Clin Nutr 1997;65:1858-66.
22. Brown RK, Wyatt H, Price JF, Kelly FJ. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 1996;9:334-9.
23. Rock CL, Dechert RE, Khilnani R, Parker RS, Rodriguez JL. Carotenoids and antioxidant vitamins in patients after burn injury. J Burn Care Rehabil 1997;18:269-78.
24. Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996;24:392-7.
25. Winklhofer-Roob BM, Puhl H, Khoschsorur G, van't Hof MA, Esterbauer H, Shmerling DH. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during β-carotene supplementation in cystic fibrosis. Free Radic Biol Med 1995;18:849-59.
26. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Collins CE, Garg ML. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 2001;20:157-65.
27. Montuschi P, Kharitonov SA, Ciabattoni G, et al. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000;55:205-9.
28. Dominguez C, Gartner S, Linan S, Cobos N, Moreno A. Enhanced oxidative damage in cystic fibrosis patients. Biofactors 1998;8:149-53.
29. Winklhofer-Roob BM, van't Hof MA, Shmerling DH. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-á-tocopherol compared with all-rac-á-tocopheryl acetate preparations. Am J Clin Nutr 1996;63:722-8.
30. Winklhofer-Roob BM, van't Hof MA, Shmerling DH. Response to oral β-carotene supplementation in patients with cystic fibrosis: a 16-month follow-up study. Acta Paediatr 1995;84:1132-6.
31. Winklhofer-Roob BM, Schlegel-Haueter SE, Khoschsorur G, van't Hof MA, Suter S, Shmerling DH. Neutrophil elastase/á 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral β-carotene supplementation. Pediatr Res 1996;40:130-4.
32. Wood LG, Fitzgerald DA, Lee AK, Garg ML. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr 2003;77:150-9.
33. Renner S, Rath R, Rust P, et al. Effects of β-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax 2001;56:48-52.
34. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003;34:1563-74.